It Takes a Community for a Winn Scholar to Build a Clinical Trial
Inspiration for Patients and Peers
Three-Drug Treatment Shows Promise for Patients with Rare Blood Cancer BPDCN
Doximity Ask AI May Be Smart, but Trusted Answers Still Depend on Physicians Like Dr. Cohn
Dana-Farber Research Supports FDA Approval of New Therapy for “Double-Positive” Metastatic Breast Cancer
Rapid Epigenetic Test Could Speed Diagnostics for Acute Leukemias
Dana-Farber Research Supports FDA Approval of New First-Line Therapy for Metastatic Triple-Negative Breast Cancer
Two Dana-Farber Hematologists Receive Top Honors From the American Society of Hematology
Dana-Farber Researcher Selected to Join the Pew Scholars Program
Fixed-Duration Triplet Therapy Demonstrates Efficacy for Patients with Relapsed/Refractory CLL
ImmunoPRISM Trial Shows Teclistamab Improves Depth of Response and Progression-Free Survival in High-Risk Smoldering Multiple Myeloma
Dana-Farber Research Supports FDA Approval of Pembrolizumab-Belzutifan Combination for Higher-Risk Clear Cell Kidney Cancer After Surgery
Staying One Step Ahead
What the Biggest ASCO Cancer Research Updates Could Mean for Patients
Fox Chase Researcher Parth Desai Receives Prestigious ASCO Career Development Award
Showing 1 - 15 of 1061 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...71 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
